These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2081483)

  • 1. Extrahepatic cell membrane lipid abnormalities and cellular dysfunction in liver disease.
    Owen JS
    Drugs; 1990; 40 Suppl 3():73-83. PubMed ID: 2081483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of extrahepatic membrane cholesterol deposition in patients with chronic liver diseases by S-adenosyl-L-methionine.
    Rafique S; Guardascione M; Osman E; Burroughs AK; Owen JS
    Clin Sci (Lond); 1992 Sep; 83(3):353-6. PubMed ID: 1327655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoproteins in liver disease.
    Seidel D
    J Clin Chem Clin Biochem; 1987 Sep; 25(9):541-51. PubMed ID: 3316478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: S-adenosyl-L-methionine--a new therapeutic agent in liver disease?
    Osman E; Owen JS; Burroughs AK
    Aliment Pharmacol Ther; 1993 Feb; 7(1):21-8. PubMed ID: 8439634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal plasma lipoproteins and lecithin-cholesterol acyltransferase deficiency in alcoholic liver disease.
    Sabesin SM; Hawkins HL; Kuiken L; Ragland JB
    Gastroenterology; 1977 Mar; 72(3):510-8. PubMed ID: 188710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma lipoprotein alterations and morphologic changes with lipid deposition in the kidney of patients with hepatorenal syndrome.
    Hovig T; Blomhoff JP; Holme R; Flatmark A; Gjone E
    Lab Invest; 1978 May; 38(5):540-9. PubMed ID: 642455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemistry and pharmacology of S-adenosyl-L-methionine and rationale for its use in liver disease.
    Chawla RK; Bonkovsky HL; Galambos JT
    Drugs; 1990; 40 Suppl 3():98-110. PubMed ID: 2081485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein metabolism in liver disease.
    Sabesin SM; Bertram PD; Freeman MR
    Adv Intern Med; 1980; 25():117-46. PubMed ID: 6987838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary iron overload and induced lipid peroxidation are associated with impaired plasma lipid transport and hepatic sterol metabolism in rats.
    Brunet S; Thibault L; Delvin E; Yotov W; Bendayan M; Levy E
    Hepatology; 1999 Jun; 29(6):1809-17. PubMed ID: 10347124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effect of fish oil feeding and other dietary fatty acids on plasma lipoproteins, biliary lipids, and hepatic expression of proteins involved in reverse cholesterol transport in the rat.
    Morgado N; Rigotti A; Valenzuela A
    Ann Nutr Metab; 2005; 49(6):397-406. PubMed ID: 16227687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discoidal bilayer structure of nascent high density lipoproteins from perfused rat liver.
    Hamilton RL; Williams MC; Fielding CJ; Havel RJ
    J Clin Invest; 1976 Sep; 58(3):667-80. PubMed ID: 182724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid parameters predicting liver function in patients with cirrhosis and after liver transplantation.
    Tietge UJ; Boker KH; Bahr MJ; Weinberg S; Pichlmayr R; Schmidt HH; Manns MP
    Hepatogastroenterology; 1998; 45(24):2255-60. PubMed ID: 9951906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperlipidemia of chronic renal failure.
    Kaysen GA
    Blood Purif; 1994; 12(1):60-7. PubMed ID: 7986478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of increased membrane cholesterol on membrane fluidity and cell function in human red blood cells.
    Cooper RA
    J Supramol Struct; 1978; 8(4):413-30. PubMed ID: 723275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in the lipid profile in chronic hepatopathies].
    Perales J; Angel Lasunción M; Cano A; Martín-Scapa MA; Matíes M; Herrera E
    Med Clin (Barc); 1994 Mar; 102(10):364-8. PubMed ID: 8182981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: lipid composition and reactivity in vitro.
    Glomset JA; Norum KR; King W
    J Clin Invest; 1970 Oct; 49(10):1827-37. PubMed ID: 5456796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein metabolism in liver disease.
    Green PH
    Lab Res Methods Biol Med; 1983; 7():199-204. PubMed ID: 6353105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in plasma lipids and lipoproteins in chronic liver diseases].
    Cavanna A; Tappero R; Brizio T; Griffa G; Garlanda PF; Molino G
    Quad Sclavo Diagn; 1981 Dec; 17(4):553-6. PubMed ID: 7347833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility.
    Anstee QM; Day CP
    J Hepatol; 2012 Nov; 57(5):1097-109. PubMed ID: 22659519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute dyslipoproteinemia induced by interleukin-2: lecithin:cholesteryl acyltransferase, lipoprotein lipase, and hepatic lipase deficiencies.
    Kwong LK; Ridinger DN; Bandhauer M; Ward JH; Samlowski WE; Iverius PH; Pritchard H; Wilson DE
    J Clin Endocrinol Metab; 1997 May; 82(5):1572-81. PubMed ID: 9141552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.